Quince Therapeutics: Leveraging Digital Banking Trends for Enhanced Patient Engagement Strategies

Digital Banking Performance Metrics Highlight Industry Growth

Quince Therapeutics, a company focused on developing innovative therapeutics for rare diseases, operates within an ecosystem increasingly influenced by advancements in digital banking technologies. The recent release of the 2025 Digital Banking Performance Metrics Report by Alkami Technology, in collaboration with Cornerstone Advisors, underscores significant trends in the digital banking sector that may have implications for healthcare companies like Quince. The report analyzes data from financial institutions with an average asset size of $4.7 billion and reveals a substantial year-over-year growth in digital banking metrics.

One of the most striking findings of the report is the 61% jump in live chat activity among participating banks and credit unions, indicating a shift towards more interactive and personalized customer service experiences. For a company like Quince Therapeutics, which relies on effective communication and engagement strategies for patient outreach and education, this trend highlights the importance of leveraging digital platforms for enhancing user experience. An increase in live chat capabilities can serve as a model for how Quince might engage with patients and healthcare providers, ensuring timely and efficient communication about its rare disease therapies.

Furthermore, the report details a rise in average bill pay adoption, which climbed to 35% in 2024, along with a notable increase in digital checking account openings, now at 21% of total openings. These developments suggest a broader acceptance of digital banking solutions among consumers, which could reflect a growing trend toward digitization in other sectors, including healthcare. As Quince Therapeutics continues to develop and deploy its therapeutic solutions, understanding these digital trends may guide the company in how it chooses to structure its own patient and provider interactions, potentially leading to an enhanced service delivery model.

In addition to the key metrics, the report employs a percentile-based benchmarking framework that provides insights into both individual and industry-wide performance. Ron Shevlin, Chief Research Officer at Cornerstone Advisors, emphasizes that these insights can help executives understand the impact of digital strategies on organizational success. As Quince Therapeutics navigates its path in the competitive biotech landscape, staying attuned to such industry benchmarks may help the company align its strategic initiatives with evolving consumer expectations.

Alkami Technology's recognition by J.D. Power for its exceptional mobile banking platform experience in 2024 and 2025 further underscores the importance of user-focused digital solutions. For companies like Quince Therapeutics, the emphasis on enhancing user experience through technology is essential, especially as the healthcare sector increasingly adopts digital tools. An exclusive webinar scheduled for April 30th at 12 PM CT will delve deeper into the report’s findings, providing additional context for stakeholders interested in the implications of digital banking trends across various industries.